Statement of Organization, Functions, and Delegations of Authority, 35676-35679 [2019-15691]

Download as PDF 35676 Federal Register / Vol. 84, No. 142 / Wednesday, July 24, 2019 / Notices banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than August 16, 2019. A. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant Vice President) 1 Memorial Drive, Kansas City, Missouri 64198–0001: 1. Fidelity Financial Bancorporation, Wichita, Kansas; to become a bank holding company upon the conversion of its subsidiary Fidelity Bank, Wichita, Kansas, to a commercial bank. Board of Governors of the Federal Reserve System, July 18, 2019. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2019–15646 Filed 7–23–19; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention khammond on DSKBBV9HB2PROD with NOTICES Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 84 FR 34177–34184, dated July 17, 2019) is amended to reflect the reorganization of the National Center on Birth Defects and Developmental Disabilities, Deputy Director for Non-Infectious Diseases, Centers for Disease Control and Prevention. This reorganization will VerDate Sep<11>2014 16:53 Jul 23, 2019 Jkt 247001 align budget lines and similar programmatic areas under the same divisions and branches. I. Under Part C, Section C–B, Organization and Functions, the following organizational unit is deleted in its entirety: • Developmental Disabilities Branch (CUBBD). II. Under Part C, Section C–B, Organization and Functions, make the following changes: • Update the functional state for the Office of the Director (CUB1). • Update the functional statements for the Resource Management Office (CUB12). • Retitle the Division of Congenital and Developmental Disorders (CUBB) to the Division of Birth Defects and Infant Disorders (CUBB) and update its functional statement. • Update the functional statement for the Office of the Director (CUBB1). • Retitle the Birth Defects Branch (CUBBB) to the Birth Defects Monitoring and Research Branch (CUBBB) and update its functional statement. • Retitle the Prevention Research and Translation Branch (CUBBC) to the Infant Outcomes Monitoring, Research and Prevention Branch (CUBBC) and update its functional statement. • Update the functional statement for the Division of Human Development and Disability (CUBC). • Update the functional statement for the Child Development and Disability Branch (CUBCB). • Retitle the Disability and Health Branch (CUBCC) to the Disability and Health Promotion Branch. III. Under Part C, Section C–B, Organization and Functions, insert the following: • Office of the Director (CUB1). (1) Directs, manages, and coordinates the activities of the NCBDDD; (2) develops goals and objectives; provides leadership, policy formulation, scientific oversight, and guidance in program planning and development; (3) coordinates NCBDDD program activities with other CDC components, federal agencies, state and local health agencies, business and industry, voluntary organizations, and community-based organizations; (4) coordinates technical assistance to states, other nations and international organizations; (5) coordinates with medical, scientific, and other professional organizations interested in birth defects prevention, pediatric genetics, developmental disabilities prevention, and disabilities and health, and prevention of complications of hereditary blood disorders; (6) advises the CDC Director on policy matters concerning NCBDDD PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 activities; (7) oversees and coordinates the translation of scientific findings for health care providers, public health professionals, and the public on these conditions; (8) ensures NCBDDD produces the highest quality, most relevant and useful science possible; (9) oversees scientific clearance of NCBDDD documents and digital materials and coordinates crossclearance of materials; (10) provides information and guidance to the staff regarding scientific issues and provides scientific leadership for the center; (11) provides ongoing communication leadership and support to NCBDDD’s Office of the Director and divisions in furthering the Centers’ mission; leads strategic planning for communications and branding of NCBDDD programs and projects; (12) leads and oversees news media strategy and evaluation; (13) facilitates clearance and cross-clearance of NCBDDD print and digital materials, ensuring adherence to CDC and Department of Health and Human Services (DHHS) information and publication policies; (14) reviews, prepares and coordinates policy and briefing documents; (15) conducts monitoring and analysis of policy issues potentially affecting NCBDDD and its constituents; and (16) provides information for the development of the NCBDDD’s annual budget submission. • Resource Management Office (CUB12). (1) Plans, coordinates, and provides administrative and management advice and guidance for NCBDDD; (2) provides and coordinates center-wide administrative, management, and support services in the areas of fiscal management, personnel, travel, procurement, facility management, and other administrative services; (3) prepares annual budget plans and budget justifications; (4) develops annual budget plans and budget justifications; (5) monitors NCBDDD spend plans to ensure ceiling levels are at or below specified levels; (6) coordinates NCBDDD requirements relating to contracts, grants, cooperative agreements, and reimbursable agreements; (7) develops and implements administrative policies, procedures, and operations, as appropriate, for NCBDDD, and prepares special reports and studies, as required, in the administrative management areas; and (8) maintains liaison with related staff offices and other officials of CDC on behalf of NCBDDD. • Division of Birth Defects and Infant Disorders (CUBB). The Division of Birth Defects and Infant Disorders works to identify causes of birth defects and infant disorders through surveillance and public health research, and E:\FR\FM\24JYN1.SGM 24JYN1 khammond on DSKBBV9HB2PROD with NOTICES Federal Register / Vol. 84, No. 142 / Wednesday, July 24, 2019 / Notices conducts prevention research and programs to improve health across the lifespan. This division: (1) Conducts epidemiological research to determine the causes and prevention of birth defects and developmental disabilities; (2) maintains and expands support for state-based surveillance; (3) evaluates the effectiveness of efforts to prevent birth defects and developmental disabilities; (4) conducts and disseminates findings of epidemiologic research, investigations, demonstrations, and programs directed toward the prevention of selected adverse reproductive outcomes that are environmentally related; (5) provides assistance to state and local health departments on community exposures to terotogenic, mutagenic, embryotoxic, other environmental agents, and genetic influences adversely interfering with normal growth and development; (6) conducts research and epidemiologic studies to develop intervention programs to reduce alcohol and other substance exposed pregnancies and monitors infant outcomes to identify and better understand the needs and develop interventions to improve the trajectory for substance exposed infants; (7) works closely with international organizations and entities in developing strategies and programs for reducing the number of birth defects and developmental disabilities; (8) develops and evaluates prevention strategies and provides training, technical consultation, and assistance to States and localities in developing their capacity for planning, establishing, and maintaining surveillance and prevention programs; (9) plans, develops, establishes, and maintains systems of surveillance including registries for monitoring, evaluating and disseminating information; (11) assists in increasing the capacity of states, localities, international organizations, and non-governmental organizations to prevent and control birth defects and developmental disabilities through training, technology transfer, grants, cooperative agreements, contracts, and other means; (12) provides information and education to the public; (13) provides services, consultation, technical assistance, and information to States, localities, other Federal agencies, international organizations, and other public and private organizations; (14) provides training in the epidemiology to professionals throughout the U.S. and abroad; and (15) collaborates and coordinates activities with other CIOs and HHS agencies. • Office of the Director (CUBB1). (1) Manages, directs, and coordinates the VerDate Sep<11>2014 16:53 Jul 23, 2019 Jkt 247001 research agenda and activities of the division; (2) provides leadership and guidance on strategic planning, policy, program and project priority planning and setting, program management, and operations; (3) establishes division goals, objectives, and priorities; (4) monitors progress in implementation of projects and achievement of objectives; (5) plans, allocates, and monitors resources; (6) provides management, administrative, and support services, and coordinates with appropriate NCBDDD offices on program and administrative matters; (7) provides liaison with other CDC organizations, other governmental agencies, international organizations, and other outside groups; (8) provides support for internal scientific advisory groups; (9) provides scientific leadership and guidance to the division to assure highest scientific quality and professional standards; and (10) researches, identifies and executes prevention messaging and interventions to reduce adverse birth outcomes. • Birth Defects Monitoring and Research Branch (CUBBB). (1) Designs and conducts epidemiologic and genetic research to identify causes and risk factors of birth defects; (2) conducts and evaluates interventions to improve infant and child health by preventing or reducing the adverse consequences of birth defects; (3) designs and conducts surveillance of selected birth defects to identify rates, trends, and patterns of occurrence, and to evaluate the effectiveness of prevention programs; (4) disseminates findings of studies to the scientific and public health communities, and to the general public; (5) provides technical assistance to state and local agencies on surveillance of birth defects, epidemiologic research, prevention program design and evaluation, and prevention effectiveness research; (6) funds and coordinates grant and cooperative agreement programs and other extramural activities to improve the knowledge base for the prevention of birth defects through surveillance, epidemiologic research, and applies research of preventive interventions; (7) coordinates activities with other CDC functional units, HHS, other federal agencies, and appropriate private organizations regarding research and prevention programs for birth defects; (8) works with international organizations in developing strategies for the prevention of birth defects; and (9) disseminates findings of research through direct contact with health authorities, publication and distribution of special reports, publication in scientific and technical journals, PO 00000 Frm 00090 Fmt 4703 Sfmt 4703 35677 conference presentations, and other appropriate means. • Infant Outcomes Monitoring, Research and Prevention Branch (CUBBC). (1) Designs and conducts surveillance of preventable birth defects due to substance exposure during pregnancy, and emerging threats to mothers and babies; (2) identifies and monitors major preconception, prenatal and perinatal risks, and protective factors for fetal alcohol spectrum disorders (FASD) and other prenatal alcohol and substance-attributable conditions and other threats to mothers and their babies; (3) identifies rates, trends, and patterns of occurrence; (4) modifies the impact of prenatal exposures leading to adverse physical and developmental impairments in infants, children, and adults including integrating successful prevention programs into social and medical environments, and evaluating innovative, effective, and strategic health promotion programs; (5) develops, implements, evaluates, and disseminates education and communication interventions that lead to the prevention of birth defects and developmental disabilities; (6) disseminates findings of epidemiologic studies to the scientific and public health communities, and to the general public; (7) conducts prevention effectiveness research to evaluate interventions strategies for the prevention of birth defects and developmental disabilities; (8) provides technical assistance to state and local agencies on surveillance, epidemiologic research, prevention program design and evaluation, and prevention effectiveness research; (9) funds and coordinates grant and cooperative agreement programs and other extramural activities to improve the knowledge base for the prevention of birth defects and developmental disabilities through surveillance, epidemiologic research, and applies research of preventive interventions; (10) coordinates activities with other CDC functional units, HHS, other federal agencies and appropriate private organizations regarding research and prevention programs for birth defects and developmental disabilities; (11) works with international organizations in developing strategies for the prevention of birth defects and developmental disabilities; and (12) disseminates finding of research through direct contact with health authorities, publication and distribution of special reports, publication in scientific and technical journals, E:\FR\FM\24JYN1.SGM 24JYN1 khammond on DSKBBV9HB2PROD with NOTICES 35678 Federal Register / Vol. 84, No. 142 / Wednesday, July 24, 2019 / Notices conference presentations, and other appropriate means. • Division of Human Development and Disability (CUBC). The Division of Human Development and Disability works to help children and adults living with Autism, Attention Deficit Hyperactivity Disorder (ADHD), Tourette Syndrome (TS) and other developmental disabilities live to the fullest through better understanding developmental disabilities from early detection into adulthood. The division improves the health for children and adults with disabilities, in particular, people with mobility limitations, intellectual disability and hearing loss by informing disability health policy and practice, and dissemination of disability health inclusion resources. This division: (1) Designs and conducts surveillance of developmental disabilities to identify rates, trends, and patterns of occurrence, and to evaluate the effectiveness of prevention programs; (2) conducts epidemiologic studies of developmental disabilities to identify causes and risk factors for these conditions; (3) disseminates findings of epidemiologic studies to the scientific and public health communities and to the general public; (4) conducts applied research on public health aspects of normal and abnormal child development (e.g., early childhood, behavior problems in children); (5) conducts research on interventions to prevent adverse child developmental outcomes; (6) develops and disseminates information on public health aspects of normal and abnormal child development; (9) conducts, analyzes, and disseminates surveillance data to identify the distribution of disabilities in state populations; health conditions that occur with greater frequency among people with disabilities; and risk and protective behaviors compared to people without disabilities; (10) assists states and localities in developing their capacity for serving individuals with developmental and other disabilities (e.g., developing prevention strategies, providing training and technical consultation) to prevent secondary conditions; (11) collaborates with universities, federal, national, and state organizations to identify and address knowledge and research gaps in developmental health and disability; (12) collaborates with universities and other organizations to investigate environmental, social, and technological supports to promote inclusion; (13) develops programs that seek to identify health risks, protective factors and measure the effectiveness of health VerDate Sep<11>2014 16:53 Jul 23, 2019 Jkt 247001 promotion activities for prevention of conditions related to disability; and (14) oversees and manages grants, cooperative agreements, contracts, and other funding instruments related to division programs. • Child Development and Disability Branch (CUBCB). (1) Promotes optimal child development and early identification of children with developmental delays through assessing, developing, implementing, disseminating and supporting evidencebased practices, tools, and resources; (2) helps children and adults with autism, ADHD, TS and other developmental disabilities live to the fullest by understanding preventable risk factors, opportunities for early intervention, and the effects of these disorders throughout the lifespan; (3) designs and conducts surveillance of developmental disabilities to identify rates, trends, and patterns of occurrence, and to evaluate the effectiveness of prevention programs; (4) conducts epidemiologic studies of developmental disabilities to identify causes and risk factors for these conditions; (5) disseminates findings of epidemiologic studies to the scientific and public health communities and to the general public; (6) conducts prevention effectiveness research to evaluate interventions strategies for the prevention of developmental disabilities; (7) conducts epidemiologic studies to identify and describe specific conditions and long-term outcomes of developmental disabilities; (8) provides technical assistance to state and local agencies on surveillance of developmental disabilities, epidemiologic research, prevention program design and evaluation, and prevention effectiveness research; (9) provides scientific leadership and technical assistance in the development, application, improvement and evaluation of public health activities, systems, and interventions supporting optimal child development, including those with or at risk for disabilities; (10) coordinates and collaborates on recommendations for policy development at the federal and state levels and with the private sector to promote social participation and optimal child development, including those with or at risk for disabilities; (11) conducts research to expand the knowledge base related to optimal early development and health of children with or at risk of disabilities, and investigates costs and effectiveness of intervention programs and systems; (12) funds and coordinates grant and cooperative agreement programs and other extramural activities to improve PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 the knowledge base for the prevention of developmental disabilities through surveillance, epidemiologic research, and applies research of preventive interventions; (13) coordinates activities with other CDC functional units, HHS, other federal agencies and appropriate private organizations regarding research and prevention programs for developmental disabilities; (14) collaborates with international organizations in developing strategies for the prevention of developmental disabilities; (15) disseminates findings of research through direct contact with health authorities, publication and distribution of special reports, publication in scientific and technical journals, conference presentations, and other appropriate means; and (16) provides training in the epidemiology of developmental disabilities to professionals throughout the United States and abroad. • Disability and Health Promotion Branch (CUBCC). (1) Assists states and localities with the development, monitoring and evaluation of early hearing detection and intervention (EHDI) tracking and surveillance systems; (2) conducts research on etiology of hearing loss and associated disabilities, cost and effectiveness and long-term benefits of early identification and intervention (3) supports statebased disability and health promotion programs, national, and state organizations that promote and inform disability policy and practice, including assessing, developing, implementing, and disseminating disability inclusion models, tools, and resources; (4) collaborates with and provides technical assistance, consultation, and training to local, state, federal, and international agencies, universities and governmental and non-governmental organizations on disability and health related issues; (5) collaborates with local, state, federal, and international agencies, and appropriate governmental and nongovernmental organizations to develop, review, and implement policies that advance the health of people with disabilities across the lifespan; (6) provides scientific leadership in the development, application, extension, and improvement of health surveillance and tracking systems related to disability and health; (7) conducts and supports both qualitative and quantitative research to expand the knowledge base related to disability and health across the lifespan; (8) disseminates information from surveillance and health services research, epidemiological research, health promotion and disease E:\FR\FM\24JYN1.SGM 24JYN1 35679 Federal Register / Vol. 84, No. 142 / Wednesday, July 24, 2019 / Notices prevention strategies, and policies related to disability and health; (9) establishes collaborative partnerships with public and private organizations of national and international stature to promote the health of people with disabilities; (10) collaborates with funded non-governmental agencies to disseminate best practices, identify areas of need, facilitate development and distribution of educational materials, and provide informational resources to states and affected populations and their caregivers; and (11) provides leadership in health promotion and disease prevention across the lifespan for individuals with disabilities. IV. Delegations of Authority: All delegations and redelegations of authority made to officials and employees of affected organizational components will continue in them or their successors pending further redelegation, provided they are consistent with this reorganization. (Authority: 44 U.S.C. 3101) Alex M. Azar II, Secretary. [FR Doc. 2019–15691 Filed 7–23–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Submission for OMB Review; Assets For Independence (AFI) Performance Progress Report (PPR) (OMB #0970– 0483) Office of Community Services; Administration for Children and Families; HHS. AGENCY: ACTION: Request for public comment. The Office of Community Services (OCS), Administration for Children and Families (ACF) is requesting approval of a three-year extension of the Assets for Independence (AFI) Performance Progress Report (PPR) Long Form and AFI PPR Short Form (OMB #0970–0483, expiration 8/31/2019). There are no changes requested to the forms. DATES: Comments due within 30 days of publication. OMB is required to make a decision concerning the collection of information between 30 and 60 days after publication of this document in the Federal Register. Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. SUMMARY: Written comments and recommendations for the proposed information collection should be sent directly to the following: Office of Management and Budget, Paperwork Reduction Project, Email: OIRA_ SUBMISSION@OMB.EOP.GOV, Attn: Desk Officer for the Administration for Children and Families. Copies of the proposed collection may be obtained by emailing infocollection@ acf.hhs.gov. Alternatively, copies can also be obtained by writing to the Administration for Children and Families, Office of Planning, Research, and Evaluation, 330 C Street SW, Washington, DC 20201, Attn: OPRE Reports Clearance Officer. All requests, emailed or written, should be identified by the title of the information collection. SUPPLEMENTARY INFORMATION: Description: The Assets for Independence (AFI) Act (Title IV of the Community Opportunities, Accountability, and Training and ADDRESSES: Educational Services Act of 1998, Public Law 105–285, [42 U.S.C. 604]) requires that organizations operating AFI projects submit semi-annual progress reports. OCS will continue collecting key information about projects funded through the AFI program. The AFI PPR will continue to collect data on project activities and attributes, where OCS will use the data to critically review the overall design and effectiveness of the program. OCS will use the data collected in the AFI PPR to prepare the annual AFI Report to Congress, to evaluate and monitor the performance of the AFI Program overall and of individual projects, and to inform and support technical assistance efforts. The AFI PPR will continue to fulfill AFI Act reporting requirements and program purposes. AFI program grantees are required to submit Standard Form Performance Progress Reports (SF–PPR) semiannually: One time per year using an abbreviated short form and one time using a long form. Both data collection instruments are available for review online at: https://www.acf.hhs.gov/ocs/resource/ afi-ppr-long-form, https://www.acf.hhs.gov/ocs/resource/ afi-ppr-short-form. Note: This request does not affect financial reporting requirements for AFI grantees. The SF–425 will still be required semiannually throughout the grant project period with a final report due 90 days after the grant project period ends. Respondents: Assets for Independence (AFI) program grantees. ANNUAL BURDEN ESTIMATES Total number of respondents Instrument khammond on DSKBBV9HB2PROD with NOTICES AFI PPR Short Form ....................................................................................... AFI PPR Long Form ........................................................................................ 145 145 Estimated Total Annual Burden Hours: 623.5. DEPARTMENT OF HEALTH AND HUMAN SERVICES Authority: Pub. L. 105–285, [42 U.S.C. 604]. Administration for Community Living Mary B. Jones, ACF/OPRE Certifying Officer. Intent To Award a Single-Source Supplement for the Senior Medicare Patrol National Resource Center [FR Doc. 2019–15731 Filed 7–23–19; 8:45 am] BILLING CODE 4184–24–P VerDate Sep<11>2014 16:53 Jul 23, 2019 ACTION: Jkt 247001 PO 00000 Notice. Frm 00092 Fmt 4703 Sfmt 4703 Annual number of responses per respondent 1 1 Average burden hours per response 0.5 3.8 Annual burden hours 72.5 551 The Administration for Community Living (ACL) announces the intent to award a single-source supplement to the current cooperative agreement held by the Northeast Iowa Area Agency on Aging, Inc. (NEI3A) for the Senior Medicare Patrol National Resource Center (SMPRC). The purpose of the SMPRC is to provide professional expertise, training, and technical E:\FR\FM\24JYN1.SGM 24JYN1

Agencies

[Federal Register Volume 84, Number 142 (Wednesday, July 24, 2019)]
[Notices]
[Pages 35676-35679]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-15691]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Disease Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority of 
the Department of Health and Human Services (45 FR 67772-76, dated 
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
amended most recently at 84 FR 34177-34184, dated July 17, 2019) is 
amended to reflect the reorganization of the National Center on Birth 
Defects and Developmental Disabilities, Deputy Director for Non-
Infectious Diseases, Centers for Disease Control and Prevention. This 
reorganization will align budget lines and similar programmatic areas 
under the same divisions and branches.
    I. Under Part C, Section C-B, Organization and Functions, the 
following organizational unit is deleted in its entirety:
     Developmental Disabilities Branch (CUBBD).
    II. Under Part C, Section C-B, Organization and Functions, make the 
following changes:
     Update the functional state for the Office of the Director 
(CUB1).
     Update the functional statements for the Resource 
Management Office (CUB12).
     Retitle the Division of Congenital and Developmental 
Disorders (CUBB) to the Division of Birth Defects and Infant Disorders 
(CUBB) and update its functional statement.
     Update the functional statement for the Office of the 
Director (CUBB1).
     Retitle the Birth Defects Branch (CUBBB) to the Birth 
Defects Monitoring and Research Branch (CUBBB) and update its 
functional statement.
     Retitle the Prevention Research and Translation Branch 
(CUBBC) to the Infant Outcomes Monitoring, Research and Prevention 
Branch (CUBBC) and update its functional statement.
     Update the functional statement for the Division of Human 
Development and Disability (CUBC).
     Update the functional statement for the Child Development 
and Disability Branch (CUBCB).
     Retitle the Disability and Health Branch (CUBCC) to the 
Disability and Health Promotion Branch.
    III. Under Part C, Section C-B, Organization and Functions, insert 
the following:
     Office of the Director (CUB1). (1) Directs, manages, and 
coordinates the activities of the NCBDDD; (2) develops goals and 
objectives; provides leadership, policy formulation, scientific 
oversight, and guidance in program planning and development; (3) 
coordinates NCBDDD program activities with other CDC components, 
federal agencies, state and local health agencies, business and 
industry, voluntary organizations, and community-based organizations; 
(4) coordinates technical assistance to states, other nations and 
international organizations; (5) coordinates with medical, scientific, 
and other professional organizations interested in birth defects 
prevention, pediatric genetics, developmental disabilities prevention, 
and disabilities and health, and prevention of complications of 
hereditary blood disorders; (6) advises the CDC Director on policy 
matters concerning NCBDDD activities; (7) oversees and coordinates the 
translation of scientific findings for health care providers, public 
health professionals, and the public on these conditions; (8) ensures 
NCBDDD produces the highest quality, most relevant and useful science 
possible; (9) oversees scientific clearance of NCBDDD documents and 
digital materials and coordinates cross-clearance of materials; (10) 
provides information and guidance to the staff regarding scientific 
issues and provides scientific leadership for the center; (11) provides 
ongoing communication leadership and support to NCBDDD's Office of the 
Director and divisions in furthering the Centers' mission; leads 
strategic planning for communications and branding of NCBDDD programs 
and projects; (12) leads and oversees news media strategy and 
evaluation; (13) facilitates clearance and cross-clearance of NCBDDD 
print and digital materials, ensuring adherence to CDC and Department 
of Health and Human Services (DHHS) information and publication 
policies; (14) reviews, prepares and coordinates policy and briefing 
documents; (15) conducts monitoring and analysis of policy issues 
potentially affecting NCBDDD and its constituents; and (16) provides 
information for the development of the NCBDDD's annual budget 
submission.
     Resource Management Office (CUB12). (1) Plans, 
coordinates, and provides administrative and management advice and 
guidance for NCBDDD; (2) provides and coordinates center-wide 
administrative, management, and support services in the areas of fiscal 
management, personnel, travel, procurement, facility management, and 
other administrative services; (3) prepares annual budget plans and 
budget justifications; (4) develops annual budget plans and budget 
justifications; (5) monitors NCBDDD spend plans to ensure ceiling 
levels are at or below specified levels; (6) coordinates NCBDDD 
requirements relating to contracts, grants, cooperative agreements, and 
reimbursable agreements; (7) develops and implements administrative 
policies, procedures, and operations, as appropriate, for NCBDDD, and 
prepares special reports and studies, as required, in the 
administrative management areas; and (8) maintains liaison with related 
staff offices and other officials of CDC on behalf of NCBDDD.
     Division of Birth Defects and Infant Disorders (CUBB). The 
Division of Birth Defects and Infant Disorders works to identify causes 
of birth defects and infant disorders through surveillance and public 
health research, and

[[Page 35677]]

conducts prevention research and programs to improve health across the 
lifespan. This division: (1) Conducts epidemiological research to 
determine the causes and prevention of birth defects and developmental 
disabilities; (2) maintains and expands support for state-based 
surveillance; (3) evaluates the effectiveness of efforts to prevent 
birth defects and developmental disabilities; (4) conducts and 
disseminates findings of epidemiologic research, investigations, 
demonstrations, and programs directed toward the prevention of selected 
adverse reproductive outcomes that are environmentally related; (5) 
provides assistance to state and local health departments on community 
exposures to terotogenic, mutagenic, embryotoxic, other environmental 
agents, and genetic influences adversely interfering with normal growth 
and development; (6) conducts research and epidemiologic studies to 
develop intervention programs to reduce alcohol and other substance 
exposed pregnancies and monitors infant outcomes to identify and better 
understand the needs and develop interventions to improve the 
trajectory for substance exposed infants; (7) works closely with 
international organizations and entities in developing strategies and 
programs for reducing the number of birth defects and developmental 
disabilities; (8) develops and evaluates prevention strategies and 
provides training, technical consultation, and assistance to States and 
localities in developing their capacity for planning, establishing, and 
maintaining surveillance and prevention programs; (9) plans, develops, 
establishes, and maintains systems of surveillance including registries 
for monitoring, evaluating and disseminating information; (11) assists 
in increasing the capacity of states, localities, international 
organizations, and non-governmental organizations to prevent and 
control birth defects and developmental disabilities through training, 
technology transfer, grants, cooperative agreements, contracts, and 
other means; (12) provides information and education to the public; 
(13) provides services, consultation, technical assistance, and 
information to States, localities, other Federal agencies, 
international organizations, and other public and private 
organizations; (14) provides training in the epidemiology to 
professionals throughout the U.S. and abroad; and (15) collaborates and 
coordinates activities with other CIOs and HHS agencies.
     Office of the Director (CUBB1). (1) Manages, directs, and 
coordinates the research agenda and activities of the division; (2) 
provides leadership and guidance on strategic planning, policy, program 
and project priority planning and setting, program management, and 
operations; (3) establishes division goals, objectives, and priorities; 
(4) monitors progress in implementation of projects and achievement of 
objectives; (5) plans, allocates, and monitors resources; (6) provides 
management, administrative, and support services, and coordinates with 
appropriate NCBDDD offices on program and administrative matters; (7) 
provides liaison with other CDC organizations, other governmental 
agencies, international organizations, and other outside groups; (8) 
provides support for internal scientific advisory groups; (9) provides 
scientific leadership and guidance to the division to assure highest 
scientific quality and professional standards; and (10) researches, 
identifies and executes prevention messaging and interventions to 
reduce adverse birth outcomes.
     Birth Defects Monitoring and Research Branch (CUBBB). (1) 
Designs and conducts epidemiologic and genetic research to identify 
causes and risk factors of birth defects; (2) conducts and evaluates 
interventions to improve infant and child health by preventing or 
reducing the adverse consequences of birth defects; (3) designs and 
conducts surveillance of selected birth defects to identify rates, 
trends, and patterns of occurrence, and to evaluate the effectiveness 
of prevention programs; (4) disseminates findings of studies to the 
scientific and public health communities, and to the general public; 
(5) provides technical assistance to state and local agencies on 
surveillance of birth defects, epidemiologic research, prevention 
program design and evaluation, and prevention effectiveness research; 
(6) funds and coordinates grant and cooperative agreement programs and 
other extramural activities to improve the knowledge base for the 
prevention of birth defects through surveillance, epidemiologic 
research, and applies research of preventive interventions; (7) 
coordinates activities with other CDC functional units, HHS, other 
federal agencies, and appropriate private organizations regarding 
research and prevention programs for birth defects; (8) works with 
international organizations in developing strategies for the prevention 
of birth defects; and (9) disseminates findings of research through 
direct contact with health authorities, publication and distribution of 
special reports, publication in scientific and technical journals, 
conference presentations, and other appropriate means.
     Infant Outcomes Monitoring, Research and Prevention Branch 
(CUBBC). (1) Designs and conducts surveillance of preventable birth 
defects due to substance exposure during pregnancy, and emerging 
threats to mothers and babies; (2) identifies and monitors major 
preconception, prenatal and perinatal risks, and protective factors for 
fetal alcohol spectrum disorders (FASD) and other prenatal alcohol and 
substance-attributable conditions and other threats to mothers and 
their babies; (3) identifies rates, trends, and patterns of occurrence; 
(4) modifies the impact of prenatal exposures leading to adverse 
physical and developmental impairments in infants, children, and adults 
including integrating successful prevention programs into social and 
medical environments, and evaluating innovative, effective, and 
strategic health promotion programs; (5) develops, implements, 
evaluates, and disseminates education and communication interventions 
that lead to the prevention of birth defects and developmental 
disabilities; (6) disseminates findings of epidemiologic studies to the 
scientific and public health communities, and to the general public; 
(7) conducts prevention effectiveness research to evaluate 
interventions strategies for the prevention of birth defects and 
developmental disabilities; (8) provides technical assistance to state 
and local agencies on surveillance, epidemiologic research, prevention 
program design and evaluation, and prevention effectiveness research; 
(9) funds and coordinates grant and cooperative agreement programs and 
other extramural activities to improve the knowledge base for the 
prevention of birth defects and developmental disabilities through 
surveillance, epidemiologic research, and applies research of 
preventive interventions; (10) coordinates activities with other CDC 
functional units, HHS, other federal agencies and appropriate private 
organizations regarding research and prevention programs for birth 
defects and developmental disabilities; (11) works with international 
organizations in developing strategies for the prevention of birth 
defects and developmental disabilities; and (12) disseminates finding 
of research through direct contact with health authorities, publication 
and distribution of special reports, publication in scientific and 
technical journals,

[[Page 35678]]

conference presentations, and other appropriate means.
     Division of Human Development and Disability (CUBC). The 
Division of Human Development and Disability works to help children and 
adults living with Autism, Attention Deficit Hyperactivity Disorder 
(ADHD), Tourette Syndrome (TS) and other developmental disabilities 
live to the fullest through better understanding developmental 
disabilities from early detection into adulthood. The division improves 
the health for children and adults with disabilities, in particular, 
people with mobility limitations, intellectual disability and hearing 
loss by informing disability health policy and practice, and 
dissemination of disability health inclusion resources. This division: 
(1) Designs and conducts surveillance of developmental disabilities to 
identify rates, trends, and patterns of occurrence, and to evaluate the 
effectiveness of prevention programs; (2) conducts epidemiologic 
studies of developmental disabilities to identify causes and risk 
factors for these conditions; (3) disseminates findings of 
epidemiologic studies to the scientific and public health communities 
and to the general public; (4) conducts applied research on public 
health aspects of normal and abnormal child development (e.g., early 
childhood, behavior problems in children); (5) conducts research on 
interventions to prevent adverse child developmental outcomes; (6) 
develops and disseminates information on public health aspects of 
normal and abnormal child development; (9) conducts, analyzes, and 
disseminates surveillance data to identify the distribution of 
disabilities in state populations; health conditions that occur with 
greater frequency among people with disabilities; and risk and 
protective behaviors compared to people without disabilities; (10) 
assists states and localities in developing their capacity for serving 
individuals with developmental and other disabilities (e.g., developing 
prevention strategies, providing training and technical consultation) 
to prevent secondary conditions; (11) collaborates with universities, 
federal, national, and state organizations to identify and address 
knowledge and research gaps in developmental health and disability; 
(12) collaborates with universities and other organizations to 
investigate environmental, social, and technological supports to 
promote inclusion; (13) develops programs that seek to identify health 
risks, protective factors and measure the effectiveness of health 
promotion activities for prevention of conditions related to 
disability; and (14) oversees and manages grants, cooperative 
agreements, contracts, and other funding instruments related to 
division programs.
     Child Development and Disability Branch (CUBCB). (1) 
Promotes optimal child development and early identification of children 
with developmental delays through assessing, developing, implementing, 
disseminating and supporting evidence-based practices, tools, and 
resources; (2) helps children and adults with autism, ADHD, TS and 
other developmental disabilities live to the fullest by understanding 
preventable risk factors, opportunities for early intervention, and the 
effects of these disorders throughout the lifespan; (3) designs and 
conducts surveillance of developmental disabilities to identify rates, 
trends, and patterns of occurrence, and to evaluate the effectiveness 
of prevention programs; (4) conducts epidemiologic studies of 
developmental disabilities to identify causes and risk factors for 
these conditions; (5) disseminates findings of epidemiologic studies to 
the scientific and public health communities and to the general public; 
(6) conducts prevention effectiveness research to evaluate 
interventions strategies for the prevention of developmental 
disabilities; (7) conducts epidemiologic studies to identify and 
describe specific conditions and long-term outcomes of developmental 
disabilities; (8) provides technical assistance to state and local 
agencies on surveillance of developmental disabilities, epidemiologic 
research, prevention program design and evaluation, and prevention 
effectiveness research; (9) provides scientific leadership and 
technical assistance in the development, application, improvement and 
evaluation of public health activities, systems, and interventions 
supporting optimal child development, including those with or at risk 
for disabilities; (10) coordinates and collaborates on recommendations 
for policy development at the federal and state levels and with the 
private sector to promote social participation and optimal child 
development, including those with or at risk for disabilities; (11) 
conducts research to expand the knowledge base related to optimal early 
development and health of children with or at risk of disabilities, and 
investigates costs and effectiveness of intervention programs and 
systems; (12) funds and coordinates grant and cooperative agreement 
programs and other extramural activities to improve the knowledge base 
for the prevention of developmental disabilities through surveillance, 
epidemiologic research, and applies research of preventive 
interventions; (13) coordinates activities with other CDC functional 
units, HHS, other federal agencies and appropriate private 
organizations regarding research and prevention programs for 
developmental disabilities; (14) collaborates with international 
organizations in developing strategies for the prevention of 
developmental disabilities; (15) disseminates findings of research 
through direct contact with health authorities, publication and 
distribution of special reports, publication in scientific and 
technical journals, conference presentations, and other appropriate 
means; and (16) provides training in the epidemiology of developmental 
disabilities to professionals throughout the United States and abroad.
     Disability and Health Promotion Branch (CUBCC). (1) 
Assists states and localities with the development, monitoring and 
evaluation of early hearing detection and intervention (EHDI) tracking 
and surveillance systems; (2) conducts research on etiology of hearing 
loss and associated disabilities, cost and effectiveness and long-term 
benefits of early identification and intervention (3) supports state-
based disability and health promotion programs, national, and state 
organizations that promote and inform disability policy and practice, 
including assessing, developing, implementing, and disseminating 
disability inclusion models, tools, and resources; (4) collaborates 
with and provides technical assistance, consultation, and training to 
local, state, federal, and international agencies, universities and 
governmental and non-governmental organizations on disability and 
health related issues; (5) collaborates with local, state, federal, and 
international agencies, and appropriate governmental and non-
governmental organizations to develop, review, and implement policies 
that advance the health of people with disabilities across the 
lifespan; (6) provides scientific leadership in the development, 
application, extension, and improvement of health surveillance and 
tracking systems related to disability and health; (7) conducts and 
supports both qualitative and quantitative research to expand the 
knowledge base related to disability and health across the lifespan; 
(8) disseminates information from surveillance and health services 
research, epidemiological research, health promotion and disease

[[Page 35679]]

prevention strategies, and policies related to disability and health; 
(9) establishes collaborative partnerships with public and private 
organizations of national and international stature to promote the 
health of people with disabilities; (10) collaborates with funded non-
governmental agencies to disseminate best practices, identify areas of 
need, facilitate development and distribution of educational materials, 
and provide informational resources to states and affected populations 
and their caregivers; and (11) provides leadership in health promotion 
and disease prevention across the lifespan for individuals with 
disabilities.
    IV. Delegations of Authority: All delegations and redelegations of 
authority made to officials and employees of affected organizational 
components will continue in them or their successors pending further 
redelegation, provided they are consistent with this reorganization.

(Authority: 44 U.S.C. 3101)

Alex M. Azar II,
Secretary.
[FR Doc. 2019-15691 Filed 7-23-19; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.